<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00192868</url>
  </required_header>
  <id_info>
    <org_study_id>DEDICATION</org_study_id>
    <nct_id>NCT00192868</nct_id>
  </id_info>
  <brief_title>Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction</brief_title>
  <official_title>Drug Elution and DIstal Protection During Percutaneous CoronAry Intervention in sT Elevation Myocardial InfarctiON. Acronym: Dedication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical, echocardiographic and angiographic&#xD;
      outcome of distal protection in the infarct related coronary artery and implantation of drug&#xD;
      eluting versus bare metal stents in patients with ST-elevation myocardial infarctions treated&#xD;
      acutely with percutaneous coronary intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2005</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ST segment resolution</measure>
    <time_frame>90 min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Late loss (difference between minimal lumen diameter in stented segment immediately after and at 8 month follow up).</measure>
    <time_frame>immediately after and at 8 month follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Restenosis</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximal elevations in blood concentrations of CK-MB enzyme and troponin-T</measure>
    <time_frame>Post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wall motion index</measure>
    <time_frame>During hospitalisation: day 3-5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal lumen diameter</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of binary restenosis (&gt;50% diameter stenosis), diameter stenosis (%) in the stented segment.</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of stent thrombosis and MACE.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Distal protection and drug eluting stent</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Acute onset typical chest pain of &lt; 12 hours' duration&#xD;
&#xD;
          -  ST-elevation of &gt; 4 mm (1mm = 0.1 mV) in contiguous leads of the electrocardiogram&#xD;
&#xD;
          -  High grade stenosis or occlusion of a native major coronary artery that can be crossed&#xD;
             with a soft or intermediate tip guidewire&#xD;
&#xD;
          -  Possibility to perform distal protection of the infarct-related artery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of previous myocardial infarction&#xD;
&#xD;
          -  Use of fibrinolytic agents for the index infarction&#xD;
&#xD;
          -  Left main stenosis&#xD;
&#xD;
          -  Heavily calcification of abdominal aorta or occlusive iliofemoral disease hampering&#xD;
             access to the coronary ostias by the femoral route&#xD;
&#xD;
          -  Known renal failure&#xD;
&#xD;
          -  Other significant cardiac disease&#xD;
&#xD;
          -  Other severe disease with an expected survival &lt; 1 year&#xD;
&#xD;
          -  Known allergy against clopidogrel or contrast media that can not be avoided/limited by&#xD;
             medication&#xD;
&#xD;
          -  Linguistic difficulties needing an interpreter&#xD;
&#xD;
          -  Gastrointestinal bleeding within 1 month&#xD;
&#xD;
          -  Childbearing potential or pregnancy&#xD;
&#xD;
          -  Participation in another study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Kelbaek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiac Cath Lab, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>September 22, 2009</last_update_submitted>
  <last_update_submitted_qc>September 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2009</last_update_posted>
  <keyword>primary PCI</keyword>
  <keyword>distal protection</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

